COMMUNIQUÉS West-GlobeNewswire

Navamedic ASA: Notice of Annual General Meeting
15/05/2018
The Annual General Meeting in Navamedic ASA will take place on Thursday 7 June 2017 at 14.00 at Felix Konferansesenter, Bryggetorget 3, Oslo. Please find attached the annual report. Notice of the meeting, has been [...]
Update: Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 30, 2018
15/05/2018
Message from the CEO During the past year, IBT passed the most important milestones in the company's history. The company's drug candidate, IBP-9414, which we believe will prevent necrotizing enterocolitis, has [...]
LIDDS broadens the scope of its technology platform by verifying NanoZolid® as subcutaneous depot for systemic delivery
15/05/2018
UPPSALA, SWEDEN - LIDDS AB (publ) is today unveiling new animal data which demonstrates that subcutaneously injected NanoZolid® can act as a depot for systemic delivery of pharmaceutically active drugs. A two week [...]
Navamedic ASA: Notice of Annual General Meeting
15/05/2018
The Annual General Meeting in Navamedic ASA will take place on Thursday 7 June 2017 at 14.00 at Felix Konferansesenter, Bryggetorget 3, Oslo. Please find attached the annual report. Notice of the meeting, has been [...]
Shire plc : Rule 2.9 Announcement
15/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 15 May 2018 Shire [...]
PCI Biotech to present at BioEquity Europe
15/05/2018
Oslo, Norway, May 15, 2018 PCI Biotech (OSE: PCIB ), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the Company at [...]
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 30, 2018
15/05/2018
Message from the CEO During the past year, IBT passed the most important milestones in the company's history. The company's drug candidate, IBP-9414, which we believe will prevent necrotizing enterocolitis, has [...]
Alavida Health Selected for C100’s 48 Hours in the Valley
15/05/2018
VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Alavida Health , a science and technology-based treatment program for alcohol addiction, announced today that they have been selected to participate in the [...]
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Saudi Arabia by Hikma Pharmaceuticals LLC
15/05/2018
Basel, Switzerland, May 15, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Hikma Pharmaceuticals LLC has launched Basilea's hospital antibiotic Zevtera ® (ceftobiprole) in Saudi Arabia. [...]
Novartis ARROW trial to assess mechanistic superiority of direct IL-17A inhibition (Cosentyx®) over IL-23 inhibition (Tremfya®*)
15/05/2018
ARROW study to assess the mechanistic superiority of direct IL-17A inhibition (Cosentyx) over IL-23 inhibition (Tremfya ® *) in clearing of Stelara ® *-resistant psoriatic plaques[1] This is the 100 th trial with [...]
Fagron shareholders approve all proposed resolutions
15/05/2018
Nazareth (Belgium) / Rotterdam (The Netherlands), 15 May 2018 Regulated information Fagron announces today that the annual general meeting of shareholders and the extraordinary shareholders meeting, both held on 14 May [...]
Probiodrug AG reports First Quarter 2018 Business Update
15/05/2018
Probiodrug AG reports First Quarter 2018 Business Update HALLE (SAALE), Germany, 15 May 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel therapeutic solutions [...]
Novartis completes tender offer for all outstanding shares of AveXis, Inc.
15/05/2018
Basel, May 15, 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced the successful completion of the previously announced tender offer by its indirect wholly-owned subsidiary, Novartis AM Merger Corporation (" [...]
Loop Industries Reports Fourth Quarter and Fiscal 2018 Consolidated Results
15/05/2018
Company used $2.2 million for the quarter and $6.4 million for the fiscal year of cash in operating activities to significantly advance its technology and fund its growth strategy Raised $8.6 million through a private [...]
Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension
15/05/2018
VANCOUVER, British Columbia, May 14, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM ) (FRANKFURT: ZSB ), announces an extension to the term of 2,073,750 common share purchase warrants (the “Warrants”) [...]
BIONOVELUS' FIRST QUARTER REPORTS
15/05/2018
FOR IMMEDIATE RELEASE — Phoenix, May 14, 2018 (GLOBE NEWSWIRE) -- / BioNovelus (OTC Pink: ONOV) has published today its first quarter of 2018 financial statements and report. This information is attached to this Press [...]
MediSix Therapeutics Launches with USD$20M Series A Financing
15/05/2018
Company will develop novel CAR-T immune engineering platform targeting T-cell malignancies SINGAPORE, May 14, 2018 (GLOBE NEWSWIRE) -- MediSix Therapeutics Pte. Ltd., a development-stage cell therapy company creating [...]
Arcturus Therapeutics Files Form 20-F
14/05/2018
SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today announced the filing of the Company’s Annual Report on Form 20-F for the fiscal year ended [...]
Mustang Bio Reports First Quarter 2018 Financial Results
14/05/2018
NEW YORK, May 14, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

Pages